Document is current
Any future updates will be listed below
-
Authors
Ohmiya, Naoki
Hirata, Ichiro
Sakamoto, Hirotsugu
Morishita, Toshifumi
Saito, Eiko
Matsuoka, Katsuyoshi
Nagaya, Tadanobu
Nagata, Shinji
Mukae, Miyuki
Sano, Koji
Suzuki, Takayoshi
Tarumi, Ken-ichi
Shimizu, Seiji
Kawashima, Kousaku
Hibi, Toshifumi
,
Ohmiya, Naoki
Hirata, Ichiro
Sakamoto, Hirotsugu
Morishita, Toshifumi
Saito, Eiko
Matsuoka, Katsuyoshi
Nagaya, Tadanobu
Nagata, Shinji
Mukae, Miyuki
Sano, Koji
Suzuki, Takayoshi
Tarumi, Ken-ichi
Shimizu, Seiji
Kawashima, Kousaku
Hibi, Toshifumi
Imamura, Akimichi
Minato, Yohei
Matsueda, Kazuhiro
Kuwata, Go
Sakaguchi, Masahiro
Saito, Daisuke
Mikami, Sakae
Fujishiro, Mitsuhiro
Fujii, Shigehiko
Umeno, Junji
Aoi, Kenji
Nutahara, Daisuke
Kinjo, Fukunori
Fujiya, Mikihiro
Harada, Keita
Matsushita, Mitsunobu
Chiba, Toshimi
Sasaki, Yutaka
Tanaka, Shinji
Aomi, Yoshiaki
Kasugai, Kunio
Yamamoto, Shojiro
Yagi, Nobuaki
Yoshie, Tomoo
Yoshida, Masaki
Fukudo, Shin
Yamada, Takanori
Kitsugi, Kensuke
Kuriyama, Shigeru
Miura, Soichiro
Fujimoto, Yoshiya
Niwa, Yasumasa
Nishikawa, Takashi
Okawa, Kiyotaka
Sanomura, Makoto
Nakamura, Masanao
Mizoshita, Tsutomu
-
Funding
Funding for this research was provided by:
Grants for research on intractable diseases from Ministry of Health, Labour and Welfare of Japan
- License Information
-
More Information
Article History
Received: 4 October 2021
Accepted: 18 May 2022
First Online: 31 May 2022
Declarations
:
: This study was reviewed and approved by the institutional review board and ethics committee of Fujita Health University Hospital (ID: HM20-253), and in accordance with the guidelines of national/international/institutional or Declaration of Helsinki. Informed consent was obtained in the form of opt-out on the web-site. Those who rejected it were excluded. All authors had access to the study data and reviewed and approved the final manuscript.
: Not applicable.
: We disclose no reports or publications that contain any materials that appear in the article. The authors have no conflicts of interest to declare including employment, consultancies, honoraria, stock ownership and options, expert testimony, grants or patents received or pending, royalties which took place in the previous three years.
